The pacemaker was returned for analysis.The production process for this device was checked.The production documents did not show any irregularities that could be linked to the complaint.All production steps were correctly executed.After receipt, the implant was subjected to a visual inspection.The housing showed slight swelling, suggesting a discharged battery.The electrical test for the implant confirmed the clinical observation.The pacemaker could not be interrogated and the antibradycardia therapy function was not available.The device was then opened and the electronic module was visually analyzed.The interior construction showed no irregularities.The battery was found in a discharged state.During the next step, the battery was separated from the electronic module and the electronic module was subjected to electrical testing.With the connection of an external power supply, the pacemaker functionality was fully functional.The power consumption was normal and no irregularities were observed.There were no indications of the electronic module malfunctioning.The battery was returned to the manufacturer and was examined in detail.The extensive battery test showed that the battery was fully discharged.Nevertheless, the analysis showed a typical discharge.There was no indication of a battery defect.Summary: the clinical observation was confirmed.The analysis showed that the root cause was the discharged battery.In spite of the detailed analysis, the reason for the discharged battery could not be determined.Neither the battery nor the electronic module exhibited signs of a defect.
|